REFERENCES
- Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480–487.
- Weatherall DJ. Hemoglobinopathies worldwide: present and future. Curr Mol Med. 2008;8(7):592–599.
- Weatherall DJ, Clegg JB. The Thalassaemia Syndromes, 4th ed. Oxford: Blackwell Science; 2001.
- Rund D, Rachmilewitz E. β-Thalassemia. N Engl J Med. 2005;353(11):1135–1146.
- Li CG, Li CF, Li Q, Li M. Thalassemia incidence and treatment in China with special reference to Shenzhen City and Guangdong Province. Hemoglobin. 2009;33(5):296–303.
- Ko T, Tseng L, Hsu P, et al. Molecular characterization of β-thalassemia in Taiwan and the identification of two new mutations. Hemoglobin. 1997;21(2):131–142.
- Lau YL, Chan LC, Chan YYA, et al. Prevalence and genotypes of α- and β-thalassemia carriers in Hong Kong – implications for population screening. N Engl J Med. 1997;336(18):1298–1301.
- Li Z, Li F, Li M, Guo R, Zhang W. The prevalence and spectrum of thalassemia in Shenzhen, Guangdong Province, People’s Republic of China. Hemoglobin. 2006;30(1):9–14.
- Lu J, Wen Y, Zheng Y, Qin C, Hong T. Molecular epidemiological analysis of α and β thalassemia in Shantou City of Guangdong Province. J Trop Med. 2008;8(2):139–141.
- Pan HF, Long GF, Li Q, et al. Current status of thalassemia in minority populations in Guangxi, China. Clin Genet. 2007;71(5):419–426.
- Xiong F, Sun M, Zhang X, et al. Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin Genet. 2010;78(2):139–148.
- Xu XM. The prevalence and spectrum of and thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004;57(5):517–522.
- Zhang CM, Wang Y, Gao LS, et al. Molecular epidemiology investigation of β-thalassemia in Zhongshan City, Guangdong Province, People’s Republic of China. Hemoglobin. 2010;34(1):55–60.
- Zhang J, Zhu BS, He J, et al. The spectrum of α- and β-thalassemia mutations in Yunnan Province of Southwestern China. Hemoglobin. 2012;36(5):464–473.
- Zheng CG, Liu M, Du J, Chen K, Yang Y, Yang Z. Molecular spectrum of α- and β-globin gene mutations detected in the population of Guangxi Zhuang Autonomous Region, People’s Republic of China. Hemoglobin. 2011;35(1):28–39.
- Yu F, Zhong CL, Zhou Q, et al. Genetic analysis of β-thalassemia mutations in the minority populations of Guizhou province. Chinese J Med Genet. 2010;27(6):700–703.
- Wu GY, Zhang XD. β-Thalassemia mutations in Fujian, Hubei, Guizhou Province of China. Chinese J Hematol. 1992;13(10):507–509.
- Wu QE, Zhou YL, Jian Y, Zeng BX, Wang WB, Xu YS. Study on genetic mutation types of β-thalassemia and prenatal diagnosis in Xiamen area. Chinese J Birth Health Hered. 2007;15(12):25–26.
- Huang HL, Xu LP, Lin N, et al. Analysis of type of gene mutation and gene frequency in 153 patients with thalassemia in Fuzhou area. Strait J Preventive Med. 2009;15(4):1–3.
- Din YF, Cheng Y, Wang Y, Wang W, Ren ZH. Study of gene mutation types of β Mediterranean anemia in Lishui area of Zhejiang province. Jiangxi J Med Lab Sci. 2005;23(6):508, 502.
- Rao ZY, Zhou HP, Zeng LH, Luo GY, Mao JH. Analysis on gene mutations of β-thalassemia in Jiangxi area. Chinese J Birth Health Hered. 2002;10(3):20–21.
- Huang H, Xu L, Lin N, et al. A new β-thalassemia deletion mutation [codon 36 (–C)] observed in a Chinese woman. Hemoglobin. 2010;34(6):599–603.
- Li DZ, Liao C, Li J. A novel β-thalassemic allele due to a thirteen nucleotide deletion: codons 54–58 (–T ATG GGC AAC CCT). Ann Hematol. 2009;88(8):799–801.
- Cai S, Eng B, Francombe W, et al. Two novel β-thalassemia mutations in the 5′ and 3′ noncoding regions of the β-globin gene. Blood. 1992;79(5):1342–1346.
- Hardison RC, Chui DHK, Giardine B, et al. HbVar: a relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat. 2002;19(3):225–233 (http://globin.cse.psu.edu).